AVXL:Anavex Life Sciences Corp Snapshot | Charting | News | Options
$3.65   0.00%  $0.00 NASDAQ 7:29a ET
November 14 '25 		Anavex Life Sciences Provides Regulatory Update on Blarcamesine for Early Alzheimer's Disease GlobeNewswire
Last  Change Exchange
Market data is delayed by at least 15 minutes.
Markets Portfolio
    Symbol Lookup
    Latest Story
    Anavex Life Sciences Provides Regulatory Update on Blarcamesine for Early Alzheimer's Disease
     GlobeNewswire
    Full Story →

    Headline News
    Anavex Life Sciences Announces Continued Long-Term Benefit from Oral Blarcamesine Compared to Decline Observed in the Alzheimer's Disease Neuroimaging Initiative (ADNI) Control Group
    7:30a ET October 29 '25 GlobeNewswire
    Anavex Life Sciences Announces Presentation at the 35th Alzheimer Europe Conference 'Connecting Science and Communities: The Future of Dementia Care'
    7:29a ET October 10 '25 GlobeNewswire
    Anavex Life Sciences Announces Successful Development of Once-Daily Oral Tablet Formulation for the ANAVEX(R)3-71 Program
    7:35a ET October 2 '25 GlobeNewswire
    More News →
    Day  0.00%Week  43.84%Month  59.41%More Charting →
    November 14 '25. Markets Closed.
    Last $3.65
    Day change   0.00%$0.00
    Open $NA
    Gap at open $NA
    Previous close $3.65
    Trading volume 7,244
    10 Day avg vol. 4,733,958
    Shares out. 85.9Mil
    Market cap. $313.1Mil
    Trading activity Below Avg.
    Previous data from yesterday, November 14 '25.

    Historical Price Performance
    3 month   61.39% 
    6 month   53.15% 
    1 year   51.04% 
    2 year   41.87% 

    Earnings
    Previous 12m -$0.57
    Next 12m Estimate -$0.58
    P/E ratio --
    Revenue 0Mil

    Market data provided by News provided by


    This site is published in the United States for U.S. residents only. The services offered within this site are available exclusively through our U.S. Financial Advisors. Stifel Nicolaus Financial Advisors may only conduct business with residents of the state in which they are properly registered. The information on this website is not an offer to sell or a solicitation of an offer to buy, any security, nor shall any such security be offered or sold to any person in any jurisdiction in which such offer, solicitation, purchase or sale may not lawfully be made.
    Important Disclosures | Privacy Notice | HIPAA Policy | Use of Information Policy | Business Continuity | Canada Trade Matching Statement

    Stifel, Nicolaus & Co., Inc. Member NYSE, FINRA, and SIPC.
    Stifel Nicolaus Canada Inc., is a member of CIPF/FCPE and IIROC
    Copyright © 2025 All rights reserved.